Second thoughts about second opinions for liver transplantation

Gene Y Im¹

Affiliations

Editorial

Gene Y Im. Liver Transpl. 2023.

. 2023 Dec 1;29(12):1253-1254.

doi: 10.1097/LVT.0000000000000262. Epub 2023 Sep 26.

Gene Y Im¹

¹ Icahn School of Medicine at Mount Sinai, Division of Liver Diseases, Recanati/Miller Transplantation Institute, New York, New York, USA.

No abstract available

Comment on

National survey of second opinions for hospitalized patients in need of liver transplantation.
Kaplan A, Lee-Riddle GS, Nobel Y, Dove L, Shenoy A, Rosenblatt R, Samstein B, Emond JC, Brown RS Jr. Kaplan A, et al. Liver Transpl. 2023 Dec 1;29(12):1264-1271. doi: 10.1097/LVT.0000000000000213. Epub 2023 Jul 14. Liver Transpl. 2023. PMID: 37439670

1. Kanwal F, Hernaez R, Liu Y, Taylor TJ, Rana A, Kramer JR, et al. Factors associated with access to and receipt of liver transplantation in veterans with End-stage Liver Disease. JAMA Intern Med. 2021;181:949–959.
1. Martin P, DiMartini A, Feng S, Brown R Jr, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59:1144–1165.
1. Arya A, Hernandez-Alejandro R, Marotta P, Uhanova J, Chandok N. Recipient ineligibility after liver transplantation assessment: A single centre experience. Can J Surg. 2013;56:E39–E43.
1. Yilma M, Kim NJ, Shui AM, Tana M, Landis C, Chen A, et al. Factors associated with liver transplant referral among patients with cirrhosis at multiple safety-net hospitals. JAMA Netw Open. 2023;6:e2317549.
1. Alshuwaykh O, Kwong A, Goel A, Cheung A, Dhanasekaran R, Ahmed A, et al. Predictors of outcomes of patients referred to a transplant center for urgent liver transplantation evaluation. Hepatol Commun. 2020;5:516–525.